But, once cancer cells become defective in TGF-β tumor-suppressive responses, they utilize TGF-β to their benefit to induce immune evasion, growth factor synthesis, conferring to an invasive phenotype with ability to metastasize [180]. The gene discussed is TGFB1; the disease is neoplasm.